Dose differentiated high-dose-rate prostate brachytherapy: a feasibility assessment of MRI-guided dose escalation to dominant intra-prostatic lesions

Journal of Contemporary Brachytherapy(2022)

引用 1|浏览7
暂无评分
摘要
We re-optimized HDR brachytherapy plans to escalate DILs dose to a mean D of > 150% while maintaining favorable prostate coverage and OARs doses. We propose DIL D dose of > 150% (22.5 Gy) as an achievable goal.
更多
查看译文
关键词
HDR brachytherapy,MRI-guided,dominant intra-prostatic lesion,prostate cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要